INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,182 | -98.2% | 62,165 | -97.9% | 0.00% | – |
| Q2 2023 | $1,347,753 | -49.8% | 3,018,482 | -7.8% | 0.00% | – |
| Q1 2023 | $2,684,000 | +52414.2% | 3,274,067 | -0.1% | 0.00% | -100.0% |
| Q4 2022 | $5,111 | -99.9% | 3,276,979 | -0.6% | 0.00% | 0.0% |
| Q3 2022 | $5,690,000 | -4.3% | 3,298,286 | -4.0% | 0.00% | 0.0% |
| Q2 2022 | $5,944,000 | -51.9% | 3,435,451 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $12,352,000 | -34.8% | 3,440,819 | -9.4% | 0.00% | -50.0% |
| Q4 2021 | $18,952,000 | -35.6% | 3,797,878 | -7.5% | 0.00% | -50.0% |
| Q3 2021 | $29,411,000 | -7.7% | 4,107,819 | +19.5% | 0.00% | 0.0% |
| Q2 2021 | $31,862,000 | +117.4% | 3,437,056 | +117.6% | 0.00% | +100.0% |
| Q1 2021 | $14,658,000 | +51.0% | 1,579,573 | +44.0% | 0.00% | +100.0% |
| Q4 2020 | $9,705,000 | +36.5% | 1,096,649 | +74.4% | 0.00% | 0.0% |
| Q3 2020 | $7,111,000 | -55.9% | 628,746 | +5.2% | 0.00% | -66.7% |
| Q2 2020 | $16,110,000 | +386.4% | 597,774 | +34.3% | 0.00% | +200.0% |
| Q1 2020 | $3,312,000 | +490.4% | 445,105 | +161.8% | 0.00% | – |
| Q4 2019 | $561,000 | -39.4% | 170,039 | -62.3% | 0.00% | – |
| Q3 2019 | $925,000 | -25.3% | 451,468 | +6.4% | 0.00% | – |
| Q2 2019 | $1,239,000 | +1026.4% | 424,411 | +1343.3% | 0.00% | – |
| Q1 2019 | $110,000 | -3.5% | 29,406 | +3.0% | 0.00% | – |
| Q4 2018 | $114,000 | -20.3% | 28,536 | +10.8% | 0.00% | – |
| Q3 2018 | $143,000 | +116.7% | 25,760 | +53.0% | 0.00% | – |
| Q2 2018 | $66,000 | -32.7% | 16,839 | -19.5% | 0.00% | – |
| Q1 2018 | $98,000 | +10.1% | 20,918 | -2.4% | 0.00% | – |
| Q4 2017 | $89,000 | +323.8% | 21,441 | +552.9% | 0.00% | – |
| Q3 2017 | $21,000 | -8.7% | 3,284 | +13.9% | 0.00% | – |
| Q2 2017 | $23,000 | +43.8% | 2,883 | +13.8% | 0.00% | – |
| Q1 2017 | $16,000 | -11.1% | 2,534 | +1.5% | 0.00% | – |
| Q4 2016 | $18,000 | +200.0% | 2,496 | +264.4% | 0.00% | – |
| Q3 2016 | $6,000 | -90.9% | 685 | -90.4% | 0.00% | – |
| Q2 2016 | $66,000 | -44.1% | 7,109 | -47.3% | 0.00% | – |
| Q1 2016 | $118,000 | +51.3% | 13,492 | +15.9% | 0.00% | – |
| Q4 2015 | $78,000 | -62.7% | 11,637 | -67.8% | 0.00% | – |
| Q3 2015 | $209,000 | -27.7% | 36,090 | +2.1% | 0.00% | – |
| Q2 2015 | $289,000 | +115.7% | 35,364 | +115.6% | 0.00% | – |
| Q1 2015 | $134,000 | +5.5% | 16,400 | +18.4% | 0.00% | – |
| Q4 2014 | $127,000 | -6.6% | 13,851 | 0.0% | 0.00% | – |
| Q3 2014 | $136,000 | – | 13,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |